Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,085 | Dovepress* | 11,324+ | 1,252 | 12,576 | |
| PubMed Central* | 761 | 239 | 1,000 | ||
| Totals | 12,085 | 1,491 | 13,576 | ||
| *Since 16 November 2018 | |||||
View citations on PubMed Central and Google Scholar